ArticleBiochemistry2013

Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.